You just read:

Sosei Heptares Notes That a Valid Marketing Authorization Application For QVM149, a Potential New Inhaled Combination Therapy For Asthma, Has Been Filed With the European Medicines Agency

News provided by

Sosei Heptares

24 May, 2019, 00:47 BST